Skin Cancer Channel
Related Channels

Zelboraf Warnings and Precautions

Allergic reactions, liver damage, or heart problems may occur in some people who take Zelboraf. Other safety precautions with this drug involve warnings of drug interactions and potential risks of taking this medication while pregnant or breastfeeding. Before beginning Zelboraf treatment, make sure your healthcare provider is aware of your complete medical history, particularly if you have an irregular heartbeat or a history of skin cancer.

What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking Zelboraf™ (vemurafenib) if you have:
  • Liver disease, such as hepatitis, cirrhosis, or liver failure
  • Kidney disease, such as kidney failure
  • A history of skin cancer
  • Frequent sun exposure
  • An irregular heartbeat
  • A heart condition known as QT prolongation or long QT syndrome
  • Been told you have low blood electrolytes, such as low blood magnesium, calcium, or potassium levels
  • Eye problems, including eye conditions known as uveitis or iritis
  • Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
5 Easy Tips to Manage Visitors During Cancer Treatment

Zelboraf Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.